Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Neoadjuvant Dose Dense Docetaxel in Stage II/III Breast Cancer
NCT00343512Phase 2Terminated
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Start
- Feb 2004
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in breast cancer, sponsored by Vanderbilt-Ingram Cancer Center. Started Feb 2004; status: terminated.
02
Drugs
docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00343512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00343512.